At the start of a new year, it’s human nature to want a crystal ball: What lies ahead, and how will it affect us? This feeling is particularly acute in times of uncertainty, when the ability to engage ...

Exelixis, Inc. (EXEL) reported mixed results for the second quarter of 2025. Adjusted earnings of 75 cents per share beat the Zacks Consensus Estimate of 65 cents. The company registered adjusted ...

Have you ever spent countless minutes—or even hours—manually deleting blank rows in Excel, only to realize there’s a faster, smarter way? For years, the process of cleaning up spreadsheets has been a ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

NBA. The NBA Draft Lottery is rigged: Internet sleuth provides evidence of the fix in favor of Dallas NBA. LeBron to Portland? Blazers hit the market as ownership begins formal sale process "There ...

Analyzing large datasets in Excel can often feel overwhelming, but using dynamic summaries with drill-down capabilities can significantly enhance your workflow. Whether you’re tracking sales, managing ...

Microsoft Excel is a widely used spreadsheet software that has been around for decades. To learn Excel, start slowly, play around with the basics, and seek out online tutorials. Excel is part of the ...

Total Revenue: $539.5 million for Q3 2024. Cabozantinib Franchise Net Product Revenues: $478.1 million for Q3 2024. License Revenues: $60.2 million for Q3 2024. Operating Expenses: Approximately $352 ...

Exelixis (EXEL) reported $539.54 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 14.3%. EPS of $0.47 for the same period compares to $0.10 a year ago ...